23andMe Holding Co.'s stock tumbled 43% early Monday, after the DNA-testing company filed for Chapter 11 bankruptcy, just months after admitting there was substantial doubt about its ability to continue as a going concern.
The company $(ME)$ has asked the court for "first-day" relief that will allow it to pay employee wages and benefits, along with vendors and suppliers. The debtors have also requested approval to reject numerous contracts, including real estate leases in Sunnyvale and South San Francisco to reduce operating costs.
The debtors are seeking authorization to pursue a structured sale of assets via an auction and sale process. A special committee has been formed and the company has hired Moelis & Co. LLC as an adviser.
(This is a breaking news story. Check back for updates)
-Ciara Linnane
For more from MarketWatch: http://www.marketwatch.com/newsviewer
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 24, 2025 06:39 ET (10:39 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。